Titia E. Vrenken

653 total citations
8 papers, 541 citations indexed

About

Titia E. Vrenken is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Titia E. Vrenken has authored 8 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Titia E. Vrenken's work include Cell death mechanisms and regulation (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Titia E. Vrenken is often cited by papers focused on Cell death mechanisms and regulation (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Titia E. Vrenken collaborates with scholars based in Netherlands, Mexico and Germany. Titia E. Vrenken's co-authors include Manon Buist‐Homan, Han Moshage, Laura Conde de la Rosa, Peter L. M. Jansen, Rick Havinga, Marieke H. Schoemaker, Klaas Poelstra, Hidde J. Haisma, Klaas Nico Faber and Manfred T. Reetz and has published in prestigious journals such as Hepatology, Free Radical Biology and Medicine and Journal of Hepatology.

In The Last Decade

Titia E. Vrenken

8 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Titia E. Vrenken Netherlands	6	265	151	123	104	99	8	541
Yang Cheng China	14	331 1.2×	144 1.0×	63 0.5×	59 0.6×	40 0.4×	36	606
Yan–Xin Chang China	12	355 1.3×	288 1.9×	81 0.7×	105 1.0×	62 0.6×	17	820
Hsiao‐Yen Ma United States	14	212 0.8×	218 1.4×	47 0.4×	167 1.6×	50 0.5×	18	583
Raja S. Mangipudy United States	15	182 0.7×	129 0.9×	87 0.7×	187 1.8×	272 2.7×	28	641
Xuanfu Xu China	14	470 1.8×	159 1.1×	186 1.5×	63 0.6×	38 0.4×	25	820
Hongyao Liu China	11	191 0.7×	133 0.9×	75 0.6×	112 1.1×	39 0.4×	30	551
Saijun Fan China	11	257 1.0×	120 0.8×	63 0.5×	61 0.6×	42 0.4×	32	581
Recaredo Infante France	12	272 1.0×	108 0.7×	115 0.9×	105 1.0×	41 0.4×	23	623
Mayrel Palestino Domínguez Mexico	9	201 0.8×	70 0.5×	99 0.8×	51 0.5×	48 0.5×	13	439

Countries citing papers authored by Titia E. Vrenken

Since Specialization

Citations

This map shows the geographic impact of Titia E. Vrenken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Titia E. Vrenken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Titia E. Vrenken more than expected).

Fields of papers citing papers by Titia E. Vrenken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Titia E. Vrenken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Titia E. Vrenken. The network helps show where Titia E. Vrenken may publish in the future.

Co-authorship network of co-authors of Titia E. Vrenken

This figure shows the co-authorship network connecting the top 25 collaborators of Titia E. Vrenken. A scholar is included among the top collaborators of Titia E. Vrenken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Titia E. Vrenken. Titia E. Vrenken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Rosa, Laura Conde de la, Titia E. Vrenken, Manon Buist‐Homan, Klaas Nico Faber, & Han Moshage. (2015). Metformin protects primary rat hepatocytes against oxidative stress‐induced apoptosis. Pharmacology Research & Perspectives. 3(2). e00125–e00125. 51 indexed citations

Vrenken, Titia E., Manon Buist‐Homan, Klaas Nico Faber, & Han Moshage. (2009). Reactive oxygen species are not involved In bile acid induced apoptosis of hepatocytes. Data Archiving and Networked Services (DANS). 21(3). 1 indexed citations

Vrenken, Titia E., et al.. (2008). The active metabolite of leflunomide, A77 1726, protects rat hepatocytes against bile acid-induced apoptosis. Journal of Hepatology. 49(5). 799–809. 18 indexed citations

Rosa, Laura Conde de la, Titia E. Vrenken, Rebekka A. Hannivoort, et al.. (2007). Carbon monoxide blocks oxidative stress-induced hepatocyte apoptosis via inhibition of the p54 JNK isoform. Free Radical Biology and Medicine. 44(7). 1323–1333. 43 indexed citations

Rosa, Laura Conde de la, Titia E. Vrenken, Manon Buist‐Homan, Peter L. M. Jansen, & Han Moshage. (2006). Metformin protects hepatocytes against oxidative stress induced apoptosis via HO-1 induction and inhibition of JNK activation. Hepatology. 19(10). 1 indexed citations

Rosa, Laura Conde de la, Marieke H. Schoemaker, Titia E. Vrenken, et al.. (2005). Superoxide anions and hydrogen peroxide induce hepatocyte death by different mechanisms: Involvement of JNK and ERK MAP kinases. Journal of Hepatology. 44(5). 918–929. 182 indexed citations

Dröge, Melloney J., Ykelien L. Boersma, Gertie van Pouderoyen, et al.. (2005). Directed Evolution of Bacillus subtilis Lipase A by Use of Enantiomeric Phosphonate Inhibitors: Crystal Structures and Phage Display Selection. ChemBioChem. 7(1). 149–157. 56 indexed citations

Schoemaker, Marieke H., Laura Conde de la Rosa, Manon Buist‐Homan, et al.. (2004). Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways†. Hepatology. 39(6). 1563–1573. 189 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact